WallStreetZen

NYSE: NVO
Novo Nordisk A S Stock

NVO Price
$73.18
Fair Value Price
N/A
Market Cap
$172.55B
52 Week Low
$49.24
52 Week High
$73.92
P/E
25.55x
P/B
18.54x
P/S
8.38x
PEG
3.14x
Dividend Yield
1.78%
Revenue
$19.54B
Earnings
$6.72B
Gross Margin
83.7%
Operating Margin
44.9%
Profit Margin
34.4%
Debt to Equity
1.35
Operating Cash Flow
$10B
Beta
0.59
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
51
Industry average

Reasons for this score

NVO ($73.18) is trading below its intrinsic value of $128.90, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
NVO is good value based on its earnings relative to its share price (25.55x), compared to the US market average 31.52x)
Valuation
NVO is good value based on its earnings relative to its share price (25.55x), compared to the US Biotechnology industry average (-2.49x)
Valuation

1 of 13

NVO News

Valuation

NVO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
25.55x
Industry
-2.49x
Market
31.52x
NVO is good value based on its earnings relative to its share price (25.55x), compared to the US market average 31.52x)
Valuation
NVO is good value based on its earnings relative to its share price (25.55x), compared to the US Biotechnology industry average (-2.49x)
Valuation

NVO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
18.54x
Industry
10.93x
Market
56.65x
NVO is good value based on its book value relative to its share price (18.54x), compared to the US market average (56.65x)
Valuation
NVO is poor value based on its book value relative to its share price (18.54x), compared to the US Biotechnology industry average (10.93x)
Valuation

NVO price to earnings growth (PEG)

For valuing profitable companies with growth potential
NVO is poor value relative to its rate of earnings growth, measured by PEG ratio (3.14x)
Valuation

NVO's financial health

Profit margin

Revenue
$4.7B
Net Income
$1.6B
Profit Margin
33.7%
NVO's Earnings (EBIT) of $8.78B can safely cover interest payments on company debt ($641.25M)
Financials
NVO's profit margin has increased (+1.9%) in the last year from (32.5%) to (34.4%)
Financials

Assets to liabilities

Assets
$21.9B
Liabilities
$12.6B
Debt to equity
0.07
NVO's short-term assets ($11.51B) exceed its short-term liabilities ($11.09B)
Financials
NVO's short-term assets ($11.51B) exceed its long-term liabilities ($1.47B)
Financials
NVO's debt has increased relative to shareholder equity (1.35), over the past 5 years ago (0.98)
Financials
NVO's debt to equity ratio (1.35) is considered high
Financials

Cash flow

Operating
$1.1B
Investing
-$754.2M
Financing
-$1.4B
NVO's operating cash flow ($9.64B) is sufficient to service the company's debt ($641.25M)
Financials

Novo Nordisk A S Stock FAQ

What is Novo Nordisk A S's quote symbol?

(NYSE: NVO) Novo Nordisk A S trades on the NYSE under the ticker symbol NVO. Novo Nordisk A S stock quotes can also be displayed as NYSE: NVO.

How much is Novo Nordisk A S's stock price per share?

(NYSE: NVO) Novo Nordisk A S stock price per share is $73.18 today (as of Jan 25, 2021).

What is the 52 week high and low for Novo Nordisk A S (NYSE: NVO)?

(NYSE: NVO) Novo Nordisk A S's 52-week high was $73.92, and its 52-week low was $49.24. It is currently -1% from its 52-week high and 48.62% from its 52-week low.

What is Novo Nordisk A S's Market Cap?

(NYSE: NVO) Novo Nordisk A S's market cap is $172.55B, as of Jan 27, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novo Nordisk A S's market cap is calculated by multiplying NVO's current stock price of $73.18 by NVO's total outstanding shares of 2,357,900,000.

How much is Novo Nordisk A S stock worth today?

(NYSE: NVO) Novo Nordisk A S currently has 2,357,900,000 outstanding shares. With Novo Nordisk A S stock trading at $73.18 per share, the total value of Novo Nordisk A S stock (market capitalization) is $172.55B.

Novo Nordisk A S stock was originally listed at a price of $2.89 in Dec 31, 1997. If you had invested in Novo Nordisk A S stock at $2.89, your return over the last 23 years would have been 2,436.57%, for an annualized return of 15.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics